Description

PRL-8-53 Powder

PRL 8-53
CAS Number	51352-88-6
Molar Mass	283.371 g·mol−1
Chemical Formula	C18H21NO2
IUPAC Name	Methyl 3-[2-[benzyl(methyl)amino]ethyl]benzoate

Introduction

PRL-8-53 Powder is a novel research compound renowned for its potential cognitive-enhancing properties. Widely explored in scientific studies, this liquid formulation offers researchers an avenue to investigate its effects on memory and cognitive functions. It is imperative to emphasize that PRL-8-53 Powder is strictly intended for research purposes, and any allusion to human consumption is explicitly prohibited.

Key Characteristics

PRL-8-53 is characterized by its unique cognitive effects, particularly in the realm of memory enhancement. Researchers have been intrigued by its potential to influence memory-related processes, making it a focal point in studies exploring cognitive function.

Research Applications

Researchers delve into various applications of PRL-8-53 Powder within the domain of cognitive research. Its distinctive characteristics make it a valuable asset in investigations related to memory enhancement and verbal retention.

Research Benefits

PRL 8-53 and Memory

PRL-8-53 has shown promise in enhancing memory function, as indicated by studies exploring its impact on memory formation, consolidation, and retrieval. Researchers investigate its potential mechanisms and applications in memory-related research.

PRL 8-53 and Verbal Retention

Scientific studies suggest that PRL-8-53 may have benefits in verbal retention. Researchers explore its effects on language-related cognitive processes, contributing valuable insights to the field of cognitive enhancement.

Summary

In summary, PRL-8-53 Powder presents itself as an intriguing research compound, particularly in the context of memory enhancement and verbal retention. However, it is crucial to reiterate that PRL-8-53 Powder is exclusively intended for research purposes, and any inference to human consumption is strictly prohibited.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Hansl NR, Mead BT. PRL-8-53: enhanced learning and subsequent retention in humans as a result of low oral doses of new psychotropic agent. Psychopharmacology (Berl). 1978 Apr 11;56(3):249-53. doi: 10.1007/BF00432846. PMID: 418433. [Read More].